ArticleCureus2026

Acquired CCDC6-RET Fusion After First-Line Osimertinib in Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Adenocarcinoma: A Case Report.

Ana Raquel S Afonso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.